Summary

Global Upstream Bioprocessing Market Size, Share, and Analysis, By Product (Bioreactors/Fermenters, Cell Culture Products, Bioreactors Accessories, Filters, Bags & Containers, and Others), By Workflow (Cell Culture, Cell Separation, and Media Preparation), By Use Type (Multi-use and Single-use), By Mode (In-house and Outsourced), By End-User (Biopharmaceutical Companies, CDMO & CROs, Research & Academic Institutes, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

PRODUCT OVERVIEW
Global Upstream Bioprocessing Market is projected to exhibit a Compound Annual Growth Rate (CAGR) of 14.4% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 12.4 billion and is projected to reach USD 54.4 billion by the completion of 2034.
Upstream bioprocessing refers to the early stages of producing biopharmaceutical products, like therapeutic proteins, vaccines, or antibodies. It includes the process of growing living cells (such as bacteria, yeast, or mammalian cells) in special bioreactors with controlled conditions. These cells have been genetically modified to make the specific biopharmaceutical product. In addition, the upstream process consists of developing cell lines, preparing media, preparing inoculum, and carrying out fermentation or cell culture. Furthermore, variables including pH, temperature, oxygenation, and nutrient availability are observed and adjusted to improve the cell growth and increase the output of production. Thus, the initial stage is important as it lays the groundwork for the subsequent processing steps, in which the desired product is isolated and transformed into its final form for consumption.

MARKET HIGHLIGHTS
Global upstream bioprocessing market is predicted to achieve a value of USD 54.4 billion in the forecasted period, due to the growing need for biopharmaceuticals as a result of the increasing incidence of chronic illnesses and an aging population on a global scale. The need for bioprocessing technologies is pushed by the growth of innovative therapies and personalized medicine methods. Moreover, innovations in bioprocessing technologies like single-use systems and high-throughput screening methods are also impacting the market. The government's initiatives and laws that promote biopharmaceutical innovation also help to boost the worldwide demand for the upstream bioprocessing market. Therefore, the upstream bioprocessing industry is expected to grow further due to the increasing demand for biopharmaceuticals and ongoing innovations in bioprocessing technology.
Global Upstream Bioprocessing Market Segments:

• By Product
o Bioreactors/Fermenters
o Cell Culture Products
o Bioreactors Accessories
o Filters
o Bags & Containers
o Others
• By Workflow
o Cell Culture
o Cell Separation
o Media Preparation
o Others
• By Use Type
o Multi-use
o Single-use
• By Mode
o In-house
o Outsourced
• By End-User
o Biopharmaceutical companies
o CDMO and CROs
o Research and academic institutes
o Others
MARKET DYNAMICS
Growth Drivers
Advancements in Biotechnology are Expected to Foster Market Expansion
Increasing Demand for Personalized Medicine and Targeted Therapies Will Aid in the Adoption of Upstream Bioprocessing Market
Restraint
High Cost and Complexity Associated with Bioprocessing Equipment

Key Players
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Sartorius AG
• Danaher Corporation
• GE Healthcare
• Lonza Group Ltd.
• Eppendorf AG
• Corning Incorporated
• Applikon Biotechnology BV
• PBS Biotech, Inc.
• Novasep Holding SAS
• Fujifilm Diosynth Biotechnologies (a subsidiary of Fujifilm Holdings Corporation)
• MilliporeSigma (the Life Science business of Merck KGaA)
• Bio-Rad Laboratories, Inc.
• Repligen Corporation
• Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)


Global Laboratory Temperature Control Units Market is further segmented by region into:
• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA


Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 3-month post-sales analyst support.

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1.Regional Market Share
1.2. Business Trends
1.3.Global Upstream Bioprocessing Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2.Public Sources
2.6.Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2.Global Upstream Bioprocessing Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Global Upstream Bioprocessing Market – Industry Insights
4.1.Industry Segmentation
4.2. COVID-19 overview of world economy
4.3. Industry Ecosystem Channel Analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7.Market Dynamics
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porter's Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. Global Upstream Bioprocessing Market
10.1.Overview
10.2. Historical Analysis (2018-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.Global Upstream Bioprocessing Market Size & Forecast 2024A-2034F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Product
11.3.1.1. Bioreactors/Fermenters
11.3.1.1.1. By Value (USD Million) 2024A-2034F
11.3.1.1.2.Market Share (%) 2024A-2034F
11.3.1.1.3.Y-o-Y Growth (%) 2024A-2034F
11.3.1.2.Cell Culture Products
11.3.1.2.1.By Value (USD Million) 2024A-2034F
11.3.1.2.2. Market Share (%) 2024A-2034F
11.3.1.2.3. Y-o-Y Growth (%) 2024A-2034F
11.3.1.3.Filters
11.3.1.3.1.By Value (USD Million) 2024A-2034F
11.3.1.3.2. Market Share (%) 2024A-2034F
11.3.1.3.3. Y-o-Y Growth (%) 2024A-2034F
11.3.1.4.Bags & Containers
11.3.1.4.1.By Value (USD Million) 2024A-2034F
11.3.1.4.2. Market Share (%) 2024A-2034F
11.3.1.4.3. Y-o-Y Growth (%) 2024A-2034F
11.3.1.5.Others
11.3.1.5.1.By Value (USD Million) 2024A-2034F
11.3.1.5.2. Market Share (%) 2024A-2034F
11.3.1.5.3. Y-o-Y Growth (%) 2024A-2034F
11.3.2. By Workflow
11.3.2.1.Cell Culture
11.3.2.1.1.By Value (USD Million) 2024A-2034F
11.3.2.1.2. Market Share (%) 2024A-2034F
11.3.2.1.3. Y-o-Y Growth (%) 2024A-2034F
11.3.2.2. Cell Separation
11.3.2.2.1. By Value (USD Million) 2024A-2034F
11.3.2.2.2.Market Share (%) 2024A-2034F
11.3.2.2.3.Y-o-Y Growth (%) 2024A-2034F
11.3.2.3. Media Preparation
11.3.2.3.1. By Value (USD Million) 2024A-2034F
11.3.2.3.2.Market Share (%) 2024A-2034F
11.3.2.3.3.Y-o-Y Growth (%) 2024A-2034F
11.3.2.4. Others
11.3.2.4.1. By Value (USD Million) 2024A-2034F
11.3.2.4.2.Market Share (%) 2024A-2034F
11.3.2.4.3. Y-o-Y Growth (%) 2024A-2034F
11.3.3. By Use Type
11.3.3.1.Multi-use
11.3.3.1.1.By Value (USD Million) 2024A-2034F
11.3.3.1.2. Market Share (%) 2024A-2034F
11.3.3.1.3. Y-o-Y Growth (%) 2024A-2034F
11.3.3.2. Single-use
11.3.3.2.1. By Value (USD Million) 2024A-2034F
11.3.3.2.2.Market Share (%) 2024A-2034F
11.3.3.2.3.Y-o-Y Growth (%) 2024A-2034F
11.3.3.2.4.
11.3.4. By Mode
11.3.4.1.In-house
11.3.4.1.1.By Value (USD Million) 2024A-2034F
11.3.4.1.2. Market Share (%) 2024A-2034F
11.3.4.1.3. Y-o-Y Growth (%) 2024A-2034F
11.3.4.2. Outsource
11.3.4.2.1. By Value (USD Million) 2024A-2034F
11.3.4.2.2.Market Share (%) 2024A-2034F
11.3.4.2.3. Y-o-Y Growth (%) 2024A-2034F
11.3.5. By End-User
11.3.5.1.Biopharmaceutical companies
11.3.5.1.1.By Value (USD Million) 2024A-2034F
11.3.5.1.2. Market Share (%) 2024A-2034F
11.3.5.1.3. Y-o-Y Growth (%) 2024A-2034F
11.3.5.2. CDMO and CROs
11.3.5.2.1. By Value (USD Million) 2024A-2034F
11.3.5.2.2.Market Share (%) 2024A-2034F
11.3.5.2.3.Y-o-Y Growth (%) 2024A-2034F
11.3.5.3. Research and academic institutes
11.3.5.3.1. By Value (USD Million) 2024A-2034F
11.3.5.3.2.Market Share (%) 2024A-2034F
11.3.5.3.3.Y-o-Y Growth (%) 2024A-2034F
11.3.5.4. Others
11.3.5.4.1.By Value (USD Million) 2024A-2034F
11.3.5.4.2. Market Share (%) 2024A-2034F
11.3.5.4.3. Y-o-Y Growth (%) 2024A-2034F
12. North America Global Upstream Bioprocessing Market Size & Forecast 2024A-2034F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product
12.3.2.By Workflow
12.3.3.By Use Type
12.3.4.By Mode
12.3.5.By End-User
12.4. Country
12.4.1. United States
12.4.2.Canada
13. Europe Global Upstream Bioprocessing Market Size & Forecast 2024A-2034F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Product
13.3.2.By Workflow
13.3.3.By Use Type
13.3.4.By Mode
13.3.5.By End-User
13.4. Country
13.4.1.Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4. Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia-Pacific Global Upstream Bioprocessing Market Size & Forecast 2024A-2034F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Product
14.3.2.By Workflow
14.3.3.By Use Type
14.3.4. By Mode
14.3.5.By End-User
14.4. Country
14.4.1.India
14.4.2.China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. Middle East and Africa Global Upstream Bioprocessing Market Size & Forecast 2024A-2034F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Product
15.3.2.By Workflow
15.3.3.By Use Type
15.3.4.By Mode
15.3.5.By End-User
15.4. Country
15.4.1.Israel
15.4.2.GCC
15.4.3.North Africa
15.4.4. South Africa
15.4.5.Rest of Middle East and Africa
16. Latin America Global Upstream Bioprocessing Market Size & Forecast 2024A-2034F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Product
16.3.2.By Workflow
16.3.3.By Use Type
16.3.4.By Mode
16.3.5.By End-User
16.4. Country
16.4.1.Mexico
16.4.2.Brazil
16.4.3.Rest of Latin America
17. Competitive Landscape
17.1. Company market share, 2023
17.2.Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1.Thermo Fisher Scientific Inc.
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2.Key Clients
18.1.4.3.Market Share
18.1.4.4.Recent News & Development (Last 3 Yrs.)
18.2. Merck KGaA
18.3. Sartorius AG
18.4. Danaher Corporation
18.5. GE Healthcare
18.6. Lonza Group Ltd.
18.7. Eppendorf AG
18.8. Corning Incorporated
18.9. Applikon Biotechnology BV
18.10. PBS Biotech, Inc.
18.11.Novasep Holding SAS
18.12. Fujifilm Diosynth Biotechnologies (a subsidiary of Fujifilm Holdings Corporation)
18.13. MilliporeSigma (the Life Science business of Merck KGaA)
18.14. Bio-Rad Laboratories, Inc.
18.15. Repligen Corporation
18.16. Other Prominent Players
19. Appendix
20.Consultant Recommendation